Literature DB >> 26081301

Lower Monoamine Oxidase-A Total Distribution Volume in Impulsive and Violent Male Offenders with Antisocial Personality Disorder and High Psychopathic Traits: An [(11)C] Harmine Positron Emission Tomography Study.

Nathan J Kolla1,2,3,4, Brittany Matthews1,2, Alan A Wilson1,2,3, Sylvain Houle1,2,3, R Michael Bagby1,2,3,5, Paul Links4,6, Alexander I Simpson3, Amina Hussain1,2, Jeffrey H Meyer1,2,3,4.   

Abstract

Antisocial personality disorder (ASPD) often presents with highly impulsive, violent behavior, and pathological changes in the orbitofrontal cortex (OFC) and ventral striatum (VS) are implicated. Several compelling reasons support a relationship between low monoamine oxidase-A (MAO-A), an enzyme that regulates neurotransmitters, and ASPD. These include MAO-A knockout models in rodents evidencing impulsive aggression and positron emission tomography (PET) studies of healthy subjects reporting associations between low brain MAO-A levels and greater impulsivity or aggression. However, a fundamental gap in the literature is that it is unknown whether brain MAO-A levels are low in more severe, clinical disorders of impulsivity, such as ASPD. To address this issue, we applied [(11)C] harmine PET to measure MAO-A total distribution volume (MAO-A VT), an index of MAO-A density, in 18 male ASPD participants and 18 age- and sex-matched controls. OFC and VS MAO-A VT were lower in ASPD compared with controls (multivariate analysis of variance (MANOVA): F2,33=6.8, P=0.003; OFC and VS MAO-A VT each lower by 19%). Similar effects were observed in other brain regions: prefrontal cortex, anterior cingulate cortex, dorsal putamen, thalamus, hippocampus, and midbrain (MANOVA: F7,28=2.7, P=0.029). In ASPD, VS MAO-A VT was consistently negatively correlated with self-report and behavioral measures of impulsivity (r=-0.50 to -0.52, all P-values<0.05). This study is the first to demonstrate lower brain MAO-A levels in ASPD. Our results support an important extension of preclinical models of impulsive aggression into a human disorder marked by pathological aggression and impulsivity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26081301      PMCID: PMC4569949          DOI: 10.1038/npp.2015.106

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  46 in total

1.  MAO A knockout attenuates adrenocortical response to various kinds of stress.

Authors:  Nina K Popova; Larissa N Maslova; Ekaterina A Morosova; Veta V Bulygina; Isabelle Seif
Journal:  Psychoneuroendocrinology       Date:  2005-08-19       Impact factor: 4.905

2.  Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder.

Authors:  James W Murrough; Shannan Henry; Jian Hu; Jean-Dominique Gallezot; Beata Planeta-Wilson; John F Neumaier; Alexander Neumeister
Journal:  Psychopharmacology (Berl)       Date:  2010-05-18       Impact factor: 4.530

3.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

4.  Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.

Authors:  J Logan; J S Fowler; N D Volkow; A P Wolf; S L Dewey; D J Schlyer; R R MacGregor; R Hitzemann; B Bendriem; S J Gatley
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

5.  Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.

Authors:  J P Finberg; J Wang; D S Goldstein; I J Kopin; K S Bankiewicz
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

6.  Risky decisions and response reversal: is there evidence of orbitofrontal cortex dysfunction in psychopathic individuals?

Authors:  D G V Mitchell; E Colledge; A Leonard; R J R Blair
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

7.  Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.

Authors:  Anna L Scott; Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

8.  Greater monoamine oxidase a binding in alcohol dependence.

Authors:  Brittany A Matthews; Stephen J Kish; Xin Xu; Isabelle Boileau; Pablo M Rusjan; Alan A Wilson; Dan DiGiacomo; Sylvain Houle; Jeffrey H Meyer
Journal:  Biol Psychiatry       Date:  2013-10-12       Impact factor: 13.382

Review 9.  Monoamine oxidase inactivation: from pathophysiology to therapeutics.

Authors:  Marco Bortolato; Kevin Chen; Jean C Shih
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

10.  Ventral striatal dopamine synthesis capacity is associated with individual differences in behavioral disinhibition.

Authors:  Andrew D Lawrence; David J Brooks
Journal:  Front Behav Neurosci       Date:  2014-03-14       Impact factor: 3.558

View more
  20 in total

Review 1.  Impulsivity and Cluster B Personality Disorders.

Authors:  Daniel Turner; Alexandra Sebastian; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

2.  [11C]Harmine Binding to Brain Monoamine Oxidase A: Test-Retest Properties and Noninvasive Quantification.

Authors:  Francesca Zanderigo; Alexandra E D'Agostino; Nandita Joshi; Martin Schain; Dileep Kumar; Ramin V Parsey; Christine DeLorenzo; J John Mann
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

Review 3.  Correlates of Aggression in Personality Disorders: an Update.

Authors:  Falk Mancke; Sabine C Herpertz; Katja Bertsch
Journal:  Curr Psychiatry Rep       Date:  2018-07-21       Impact factor: 5.285

Review 4.  The role of monoamine oxidase A in aggression: Current translational developments and future challenges.

Authors:  Sean C Godar; Paula J Fite; Kenneth M McFarlin; Marco Bortolato
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-01-09       Impact factor: 5.067

5.  Relationship between brain stem volume and aggression in children diagnosed with autism spectrum disorder.

Authors:  Rebecca A Lundwall; Kevin G Stephenson; E Shannon Neeley-Tass; Jonathan C Cox; Mikle South; Erin D Bigler; Emily Anderberg; Molly D Prigge; Blake D Hansen; Janet E Lainhart; Ryan O Kellems; Jo Ann Petrie; Terisa P Gabrielsen
Journal:  Res Autism Spectr Disord       Date:  2016-12-09

6.  A Bayesian Account of Psychopathy: A Model of Lacks Remorse and Self-Aggrandizing.

Authors:  Aaron Prosser; Karl J Friston; Nathan Bakker; Thomas Parr
Journal:  Comput Psychiatr       Date:  2018-10

Review 7.  Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology.

Authors:  John P M Finberg; Jose M Rabey
Journal:  Front Pharmacol       Date:  2016-10-18       Impact factor: 5.810

Review 8.  Monoamine Oxidase A in Antisocial Personality Disorder and Borderline Personality Disorder.

Authors:  Nathan J Kolla; Sarah A Vinette
Journal:  Curr Behav Neurosci Rep       Date:  2017-02-03

9.  Monoamine Oxidase-A Genetic Variants and Childhood Abuse Predict Impulsiveness in Borderline Personality Disorder.

Authors:  Nathan J Kolla; Jeffrey Meyer; Marcos Sanches; James Charbonneau
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-11-30       Impact factor: 2.582

10.  Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits.

Authors:  Nathan J Kolla; Raihaan Patel; Jeffrey H Meyer; M Mallar Chakravarty
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.